1. Home
  2. Detail

@celebrity.aux: The first thing Ryan Bingham did after getting rich was abandon his wife, but she ended up having the last laugh!#usa #fyp #celebrity #foryou #ryanbingham

celebrity.AUX
celebrity.AUX
Open In TikTok:
Region: US
Wednesday 04 December 2024 09:35:32 GMT
28671
279
10
44

Music

Download

No Watermark .mp4 (14.62MB) No Watermark(HD) .mp4 (11.01MB) Watermark .mp4 (14.04MB) Music .mp3

Comments

diane.pennington2
Diane Pennington :
He’s a musician….and was one before acting.
2025-05-29 04:39:15
3
00admir
Admir🏴‍☠️⚡️ :
He Still makes good music. Next question.
2024-12-18 19:02:35
12
dawnrenecamble
❌️Simply.Dawn❌️ :
🥰
2024-12-16 13:35:35
0
user1234561212121122
User132536375 :
😁😁😁
2025-01-26 19:01:40
0
blankitaflor
Blanca Osorio :
😂😂😂
2025-09-12 14:22:28
0
bigheff8
Bigheff :
He sucks
2024-12-04 10:00:57
4
tephy_317_
S7eph💫🐆 :
So Hassie is a Hussie 😂
2025-06-16 14:50:00
2
dawnrenecamble
❌️Simply.Dawn❌️ :
typical
2024-12-16 13:34:58
1
fatty_burrito
celi :
Hassey sucks too.
2024-12-11 22:19:00
4
To see more videos from user @celebrity.aux, please go to the Tikwm homepage.

Other Videos
#fyp #jetski #chicago #viral
#fyp #jetski #chicago #viral
Replying to @pooki.sama Nen, apnar Video 🥲🤌
Replying to @pooki.sama Nen, apnar Video 🥲🤌
ryupat is fate, ryujin red and patji blue ryujinpatji purple ❤️💙💜 #ryujinpatji #rryjinnn #chira_patt #20liststheseries
ryupat is fate, ryujin red and patji blue ryujinpatji purple ❤️💙💜 #ryujinpatji #rryjinnn #chira_patt #20liststheseries
Cam sữa ngọt ngào đồ đó, xinh nhen #timephoriavn #timephoria
Cam sữa ngọt ngào đồ đó, xinh nhen #timephoriavn #timephoria
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.

About

Legal